๐ท Bordetella pertussis enters the respiratory tract after inhalation and destroys the ciliated epithelial cells of the trachea and bronchi through toxins.
๐งช If strong clinical suspicion of whooping cough, refer to microbiology for a pernasal swab for immediate processing to improve isolation rates of B. pertussis.
๐ About
- ๐ The characteristic "whoop" is the sudden inspiration heard at the end of a bout of coughing.
- ๐ฎ Whoops (not always heard) are caused by inspiration against a closed glottis.
- ๐ค Humans are the only known reservoir for Bordetella pertussis.
๐ Vaccination
- ๐ก๏ธ Whooping cough is reduced with the DTP (Diphtheria, Tetanus, Pertussis) vaccine.
- โ ๏ธ The vaccine is not always fully protective โ ~30% of severe infections occur in fully vaccinated siblings.
- ๐คฐ Maternal vaccination during pregnancy reduces risk in babies.
- ๐ Immunity wanes steadily through childhood โ booster programmes are important.
๐ฆ Aetiology
- Caused by infection with Bordetella pertussis.
- Similar illness can be caused by Bordetella parapertussis.
- ๐คง Co-infection with RSV is common.
- Incubation period: โณ 1โ2 weeks.
- Pathogenesis: Destroys ciliated respiratory epithelium โ impaired mucus clearance.
โฃ๏ธ Toxin Production
- ๐งช Pertussis toxin: โ host cell cAMP โ disrupts protein regulation, prolongs symptoms.
- ๐ฅ Tracheal cytotoxin: Destroys ciliated epithelial cells in trachea & bronchi.
- ๐ฉธ Hemagglutinin: Adhesion molecule helping bacterial attachment.
- ๐ Adenylate cyclase toxin: Suppresses host immunity, reducing bacterial clearance.
๐ฌ Characteristics
- Gram-negative coccobacillus.
- Strict aerobe, fastidious growth.
- Non-motile, non-capsulated.
๐ฉบ Clinical Features
๐ถ Infants may present with apnoea and bouts of coughing ending in vomiting ยฑ cyanosis. Symptoms are often worse at night or after feeds.
โ ๏ธ Hypoxia โ risk of neurological damage.
- Stage 1 (Catarrhal): ๐คง Coryza-type illness (runny nose, mild cough, malaise).
- Stage 2 (Paroxysmal): Violent bouts of coughing with/without characteristic "whoop".
- Stage 3 (Convalescent): Gradual recovery but cough may last weeks โ โ100 day cough.โ
- Complications: ๐ฌ๏ธ Bronchiectasis, cyanosis, lobar collapse, CNS bleeds (rare).
๐งช Investigations
- ๐ Pernasal swab for culture on Bordet-Gengou agar.
- โก PCR testing โ rapid, sensitive diagnosis.
๐ Management
- ๐ฅ Refer infants <6 months (apnoea risk) and vulnerable patients for specialist care.
- ๐ข Notify infectious diseases consultant โ pertussis is a notifiable disease.
- Antibiotics: Azithromycin 500 mg daily ร 3 days (or other macrolides).
- ๐จโ๐ฉโ๐ง Prophylaxis: Treat unimmunised close contacts (siblings, household members).
- Critical care: Severe cases may require ventilation or ECMO support.
โ ๏ธ Complications
- ๐ฐ๏ธ Prolonged cough (โ100-day coughโ).
- ๐ฉธ Coughing bouts โ petechiae, conjunctival haemorrhage, rare CNS bleeds.
- ๐ Cough-related injuries: hernias, lingual frenulum tears.
- โ ๏ธ Infant mortality possible; late bronchiectasis in survivors.